Facebook
Facebook

1.1.11.3. Neurology and Parkinson disease

Bibliographic Records

Treating acute migraine attacks in older people

OBJECTIVE The purpose of this prospective study was the treatment procedure of migraine in older people. POPULATION-METHODS during the seven-year period 1999-2006, 93 older people of similar racial morphology, who were diagnosed after a migraine attack, were studied. Initially, they

Neuropsychiatric manifestations in Parkinson’s disease

Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease affecting 1–2% of the population over 60. Although diagnosed by its characteristic motor manifestations, PD may be preceded, and is frequently accompanied, by a wide range of

Biomarkers in Parkinson’s disease – the PPMI study (Parkinson’s Progression Markers Initiative)

Given recent advances in the understanding of the pathogenesis of Parkinson’s disease and the prospects of neuroprotective therapies, it is imperative to develop novel biomarkers which could facilitate the diagnosis and follow up of afflicted patients. Such biomarkers could involve

Objective clinical evaluation of the patient with Parkinson’s disease: the usefulness of various rating scales

Assessment of Parkinson’s disease (PD) is a complex process as a consequence of the variety of motor and non-motor symptoms as well as treatment complications, that can be present in a patient. A significant number of rating scales and questionnaires,

Fatigue assessment in Parkinson’s disease

Background: Fatigue is a major non-specific symptom in a number of disorders including Parkinson’s disease (PD). Fatigue is a vague concept and although it is understood by all, it is hard to define and much more difficult to measure precisely.

The effectiveness and safety of intravenous thrombolysis for acute ischemic stroke: the experience in Greece

The effectiveness and safety of intravenous thrombolysis (IVT) in treating patients with acute ischemic stroke (AIS) has been well established. However the total number of patients treated with IVT in Greece is limited. SITS-ISTR (Safe Implementation of Thrombolysis in Stroke-